spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  MammaPrint 

 HSMN NewsFeed - 21 Oct 2020
MammaPrint(R) Approved for Reimbursement in Germany
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 3 Jan 2020
Breast Cancer Patients in Germany Now have Insurance Coverage for MammaPrint(R) Testing through Techniker Krankenkasse
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 9 Oct 2018
Agendia Announces Level 1 Inclusion of MammaPrint(R) Breast Cancer Test in Updated National Comprehensive Cancer Network(R) (NCCN) Guidelines
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 18 Sep 2018
Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
Diagnostics Personalized Medicine Oncology Product Launch
 HSMN NewsFeed - 1 May 2018
Agendia's MammaPrint(R) Receives Positive Coverage Decisions from Three Major Private Healthcare Insurers
Diagnostics Personalized Medicine Oncology Reimbursement
 HSMN NewsFeed - 19 Dec 2017
Agendia and Bluebee Partner to Bring New NGS-based MammaPrint(R) BluePrint(R) Breast Cancer Kit to Market
Diagnostics Personalized Medicine Oncology Product Launch
 HSMN NewsFeed - 17 Feb 2014
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
Diagnostics Oncology
 HSMN NewsFeed - 10 Jul 2012
Agendia Welcomes Dr. Mark Gittleman to Expanding Medical Advisory Board
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 9 Jul 2012
Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 1 Jun 2012
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 22 Mar 2012
First-Ever Prospective Diagnostic Study in Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 6 Dec 2011
Agendia Introduces the SYMPHONY(TM) Breast Cancer Profile With Paraffin Embedded Tissue
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 17 Dec 2009
FDA Broadens Clearance for Agendia's MammaPrint(R)
Diagnostics Oncology FDA
 HSMN NewsFeed - 22 Sep 2009
Agendia Raises US $23 Million in Series E Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 18 Feb 2009
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 4 Feb 2009
Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
Diagnostics Oncology
 HSMN NewsFeed - 12 Dec 2008
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 4 Sep 2008
Agendia Launches TargetPrint(R) for Breast Cancer Patients
Diagnostics Oncology
 HSMN NewsFeed - 15 Jul 2008
Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets
Diagnostics
 HSMN NewsFeed - 17 Dec 2007
MammaPrint(R) Breast Cancer Test Shown To Be Powerful Tool for Prognosis Prediction in Postmenopausal Breast Cancer Patients
Diagnostics Oncology
 HSMN NewsFeed - 14 Dec 2007
Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen
Diagnostics Oncology
 HSMN NewsFeed - 12 Dec 2007
Agendia's MammaPrint(R), the Only FDA-Cleared Breast Cancer Prognosis Test, is Now Widely Available to U.S. Patients
Diagnostics Oncology FDA
 HSMN NewsFeed - 6 Feb 2007
Agendia Receives U.S. FDA Clearance for MammaPrint Breast Cancer Diagnostic Test
Diagnostics FDA
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.